205 related articles for article (PubMed ID: 24510913)
1. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy.
Vannucchi G; Perrino M; Rossi S; Colombo C; Vicentini L; Dazzi D; Beck-Peccoz P; Fugazzola L
Eur J Endocrinol; 2010 Jan; 162(1):145-51. PubMed ID: 19828692
[TBL] [Abstract][Full Text] [Related]
3. Outcome of differentiated thyroid cancer diagnosed in pregnant women.
Moosa M; Mazzaferri EL
J Clin Endocrinol Metab; 1997 Sep; 82(9):2862-6. PubMed ID: 9284711
[TBL] [Abstract][Full Text] [Related]
4. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
Mihailovic J; Nikoletic K; Srbovan D
J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
[TBL] [Abstract][Full Text] [Related]
5. Remnant uptake as a postoperative oncologic quality indicator.
Schneider DF; Ojomo KA; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1269-76. PubMed ID: 23373869
[TBL] [Abstract][Full Text] [Related]
6. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
Pires BP; Alves PA; Bordallo MA; Bulzico DA; Lopes FP; Farias T; Dias F; Lima RA; Santos Gisler IC; Coeli CM; Carvalhaes de Oliveira RV; Corbo R; Vaisman M; Vaisman F
Thyroid; 2016 Oct; 26(10):1480-1487. PubMed ID: 27540892
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy as a risk factor for thyroid cancer progression.
Rakhlin L; Fish S
Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):326-329. PubMed ID: 29965867
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Nodules and Thyroid Cancer in Pregnancy.
Sullivan SA
Clin Obstet Gynecol; 2019 Jun; 62(2):365-372. PubMed ID: 30925552
[TBL] [Abstract][Full Text] [Related]
11. Low but measurable stimulated serum thyroglobulin levels <2 µg/L frequently predict incomplete response in differentiated thyroid cancer patients.
Aldawish M; Jha N; McEwan AJ; Severin D; Ghosh S; Morrish DW
Endocr Res; 2014; 39(4):157-63. PubMed ID: 24460082
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid nodule and cancer in pregnant women].
Glinoer D
Ann Endocrinol (Paris); 1997; 58(3):263-7. PubMed ID: 9239253
[TBL] [Abstract][Full Text] [Related]
13. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
Elisei R; Molinaro E; Agate L; Bottici V; Masserini L; Ceccarelli C; Lippi F; Grasso L; Basolo F; Bevilacqua G; Miccoli P; Di Coscio G; Vitti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1516-27. PubMed ID: 20156922
[TBL] [Abstract][Full Text] [Related]
14. Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina.
Cabezón CA; Carrizo LC; Costanzo PR
Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):307-11. PubMed ID: 23828435
[TBL] [Abstract][Full Text] [Related]
15. Clinical guidelines for management of thyroid nodule and cancer during pregnancy.
Galofré JC; Riesco-Eizaguirre G; Alvarez-Escolá C;
Endocrinol Nutr; 2014 Mar; 61(3):130-8. PubMed ID: 24176541
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of diffuse hepatic visualization and thyroid bed uptake on post-ablative iodine-131 whole body scan in differentiated thyroid cancer.
Kim K; Kim SJ; Kim IJ; Kim YK; Kim BS; Pak K
Onkologie; 2012; 35(3):82-6. PubMed ID: 22414970
[TBL] [Abstract][Full Text] [Related]
17. Management of differentiated thyroid cancer diagnosed during pregnancy.
Vini L; Hyer S; Pratt B; Harmer C
Eur J Endocrinol; 1999 May; 140(5):404-6. PubMed ID: 10229904
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Cancer in Pregnancy.
Yu SS; Bischoff LA
Semin Reprod Med; 2016 Nov; 34(6):351-355. PubMed ID: 27741551
[TBL] [Abstract][Full Text] [Related]
19. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
